<DOC>
	<DOCNO>NCT02344134</DOCNO>
	<brief_summary>The purpose study describe immunogenicity safety cell culture-derived influenza vaccine compare egg-derived influenza vaccine among subject . To describe immunogenicity , antibody level evaluate hemagglutination inhibition ( HI ) assay serum obtain pre-vaccination 21 day post-vaccination . To describe safety , time onset duration local systemic solicit adverse event assess report . Unsolicited adverse event serious adverse event collect categorize throughout study period .</brief_summary>
	<brief_title>Study Egg-derived Influenza Vaccine Cell Culture-derived Influenza Vaccine Adult Elderly Subjects</brief_title>
	<detailed_description>This multi-center , randomize , double-blind study healthy adult elderly subject . Subjects receive single dose one influenza vaccine formulation provide blood sample immunogenicity assessment .</detailed_description>
	<mesh_term>Influenza , Human</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Healthy adult age 19 year old . The subject give write consent participate study voluntarily able comply study requirement . If female capable bearing child , subject negative urine pregnancy test result screen agrees employ adequate birth control measure study period . Subjects hypersensitive component vaccine , i.e. , egg , chicken chicken product . Subjects immune deficiency disorder . History GuillainBarre syndrome . Thrombocytopenia bleed disorder contraindicate intramuscular vaccination . Subjects experience fever within 24 hour vaccination febrile disease ( exceed 38.0â„ƒ ) screen day acute respiratory infection . Subjects receive immunosuppressant immunemodifying drug within 3 month screen . Subjects receive blood product immunoglobulin within 3 month screen . Subjects receive influenza vaccination within 6 month prior screen . Subjects receive vaccination within month screening , another vaccination schedule within month study vaccination . Subjects participate clinical trial within 4 week prior study vaccination . Subjects do blood donation within week prior study vaccination plan blood donation within 7 month study vaccination . Subjects clinically significant chronic disease malignant cancer . Pregnant woman , breastfeed woman . Any condition , opinion Investigator , prevents subject participate study .</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2014</verification_date>
</DOC>